Answer
Oct 23, 2025 - 11:23 AM
Do you have the same question? Follow this Question
Oct 23, 2025 - 11:23 AM
We’ve provided several answers to questions related to Tagrisso (Osimertinib) , see some other helpful Q&A related to this product.
Question: What are some serious warnings associated with this product?
Answer: Serious warnings include risks of interstitial lung disease, QT interval prolongation, cardiomyopathy, keratitis, severe skin disorders, cutaneous vasculitis, and aplastic anemia. Understanding these risks helps patients and healthcare providers make informed decisions and monitor for serious adverse events.
Question: What is the recommended storage condition for the product?
Answer: The recommended storage condition is at 25°C (77°F) and out of children’s reach. Proper storage ensures the medication remains effective and safe for use over its shelf life.